Autolus Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 02/17/2026 | 30.01 M | $59.71 M | 15.33% | 11.27% |
| BLACKSTONE INC. | 02/17/2026 | 20.49 M | $40.77 M | 0.00% | 7.70% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 17.50 M | $34.83 M | 12.18% | 6.58% |
| SYNCONA PORTFOLIO LTD | 02/05/2026 | 16.64 M | $33.12 M | 0.00% | 6.25% |
| TFG ASSET MANAGEMENT GP LTD | 02/17/2026 | 9.50 M | $18.91 M | 0.00% | 3.57% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 9.49 M | $18.69 M | 12.52% | 3.57% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 4.62 M | $9.20 M | 0.00% | 1.74% |
| BLACKROCK, INC. | 02/12/2026 | 3.69 M | $7.33 M | 6.07% | 1.38% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 3.36 M | $6.69 M | 100.00% | 1.26% |
| LAURION CAPITAL MANAGEMENT LP | 02/17/2026 | 3.32 M | $6.60 M | 0.00% | 1.25% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 3.11 M | $6.18 M | -36.38% | 1.17% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.96 M | $3.90 M | -3.39% | 0.74% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 1.80 M | $3.58 M | -2.66% | 0.68% |
| MORGAN STANLEY | 02/13/2026 | 1.40 M | $2.78 M | 15.12% | 0.53% |
| HEALTHINVEST PARTNERS AB | 02/06/2026 | 1.17 M | $2.33 M | 0.00% | 0.44% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.16 M | $2.31 M | -80.81% | 0.44% |
| CETERA INVESTMENT ADVISERS | 02/17/2026 | 1.10 M | $2.19 M | 37.25% | 0.41% |
| JPMORGAN CHASE & CO | 02/11/2026 | 979.28 K | $1.95 M | 8.44% | 0.37% |
| UBS GROUP AG | 01/29/2026 | 877.10 K | $1.75 M | 113.58% | 0.33% |
| ALPHABET INC. | 02/13/2026 | 698.26 K | $1.39 M | 0.00% | 0.26% |
| JANE STREET GROUP, LLC | 02/12/2026 | 681.00 K | $1.36 M | -22.12% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 598.99 K | $1.19 M | 153.99% | 0.23% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 453.83 K | $903.12 K | 7.91% | 0.17% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/03/2026 | 326.25 K | $649.23 K | 5.64% | 0.12% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 305.36 K | $607.66 K | 100.00% | 0.11% |
| EDENTREE ASSET MANAGEMENT LTD | 02/12/2026 | 300.00 K | $594.00 K | 0.00% | 0.11% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 282.11 K | $561.41 K | 36.52% | 0.11% |
| MARSHALL WACE, LLP | 02/13/2026 | 270.28 K | $537.85 K | -57.90% | 0.10% |
| AUBREY CAPITAL MANAGEMENT LTD | 02/04/2026 | 225.20 K | $444.97 K | -3.95% | 0.08% |
| DIAMETRIC CAPITAL, LP | 02/13/2026 | 199.92 K | $397.84 K | -22.28% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 197.08 K | $392.20 K | -14.73% | 0.07% |
| ERSTE ASSET MANAGEMENT GMBH | 02/11/2026 | 195.00 K | $364.65 K | 0.00% | 0.07% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 179.32 K | $356.84 K | 0.00% | 0.07% |
| ARIZONA PSPRS TRUST | 02/11/2026 | 150.00 K | $298.50 K | 100.00% | 0.06% |
| XTX TOPCO LTD | 02/17/2026 | 129.25 K | $257.20 K | -49.78% | 0.05% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 03/04/2026 | 123.28 K | $245.33 K | 333.99% | 0.05% |
| CLEARSTEAD ADVISORS, LLC | 02/09/2026 | 121.11 K | $241.00 K | 0.00% | 0.05% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 119.55 K | $238.00 K | 100.00% | 0.04% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 02/06/2026 | 112.50 K | $223.88 K | 100.00% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 110.58 K | $220.05 K | -32.70% | 0.04% |
| 02/06/2026 | 100.00 K | $199.00 K | 0.00% | 0.04% | |
| HIGHPOINT ADVISOR GROUP LLC | 02/04/2026 | 92.80 K | $184.67 K | 5.10% | 0.03% |
| 02/13/2026 | 84.85 K | $168.85 K | 100.00% | 0.03% | |
| STATE STREET CORP | 02/13/2026 | 81.83 K | $162.84 K | -1.55% | 0.03% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 66.68 K | $133.00 K | 64.89% | 0.03% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 66.58 K | $132.49 K | 100.00% | 0.03% |
| RATHBONES GROUP PLC | 02/06/2026 | 65.00 K | $129.35 K | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 57.92 K | $115.26 K | 327.35% | 0.02% |
| CITADEL ADVISORS LLC | 02/17/2026 | 54.90 K | $109.25 K | 357.50% | 0.02% |
| AVANZA FONDER AB | 01/12/2026 | 53.52 K | $106.51 K | 0.00% | 0.02% |
Autolus Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 125 institutional investors and hedge funds held shares of Autolus Therapeutics plc. The most heavily invested institutionals were:
UBS Group AG: 1.31 M
Alphabet Inc.: 698,262
Privium Fund Management B.V.: 363,430
JANE STREET GROUP, LLC: 245,785
WELLS FARGO & COMPANY/MN: 207,856
Erste Asset Management GmbH: 195,000
52.34% of Autolus Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 152.58 M shares in the last 24 months. This purchase volume represents approximately $247.18 M in transactions.